My husband and I saw Dr. Matthew Smith at Mass General today. Everyone's satisfied with the trend: the 1.8 PSA today dropped down from 4.08 on 2/28/19. This is nine weeks after Zytiga/Prednisone was added to Lupron on 2/9/2019. I recently added Alkaline Phostaphase data to the signature below. Here's a link someone posted awhile back about positive prognosticators on Lupron/Zytiga/Prednisone:
ncbi.nlm.nih.gov/pubmed/269...
It's good if PSA goes down by half at 12 weeks and ALP bounces a bit. My husband is only at 9 weeks but he's easily down by half on PSA since Zytiga initiation, and the ALP went up then down. Hope that's not too fast, but we'll take it for now but maybe others can read the tea leaves better than I can.
Here's his signature with the updates.
Husband 70 yrs (74 now) pacemaker; Agent Orange 9/14: blood in urine; DRE suspicious 11/14: biopsy G 9 (4+5), PSA: 3.32 high Gleason, low PSA, PNI involved
Lupron taken for 33 mos (currently on Lupron again after a year hiatus.)
6/15: 9 wks IMRT
9/15= .14
1/16= .093
4/16= .079
11/16=.05 (nadir)
2/17-5/17=.05
1/18=.08
2/18=.20
4/18=0.98
6/18= 3-4 bone mets seen on CT scan
7/18= 3.29 (ALP 73)
8/28= 9.0 Lupron re-started with a month of Casodex
11/27/18=7.0
2/9/19 Zytiga/Prednisone started with ongoing Lupron
2/28/19=4.02 (ALP 85)
4/11/19=1.80 (ALP 68)